Acetaminophen News and Research RSS Feed - Acetaminophen News and Research

The pain-reliever acetaminophen (also known as paracetomol) is one of the best-selling over-the-counter medications, used by more than 200 million Americans a year. It is sold under many brand names, including Tylenol, and is an ingredient in nearly 200 medications, both over-the-counter (such as Excedrin, Midol, NyQuil, and Sudafed) and prescription (such as Vicodin).
Oatmeal breakfast results in greater fullness, lower hunger ratings and fewer calories intake at lunch

Oatmeal breakfast results in greater fullness, lower hunger ratings and fewer calories intake at lunch

A new study suggests that your breakfast cereal choice may affect how full you feel and how much you eat for lunch, especially if you're overweight. According to new research published in the latest issue of the Annals of Nutrition and Metabolism, scientists found that having oatmeal (Quaker Oats Quick 1-minute™) for breakfast resulted in greater fullness, lower hunger ratings and fewer calories eaten at the next meal compared to a calorie-matched breakfast of a ready-to-eat cereal (RTEC) - sugared corn flakes. [More]
Morphine after tonsillectomy may be life threatening for children

Morphine after tonsillectomy may be life threatening for children

Treating post-operative pain with morphine can cause life-threatening respiratory problems in some children who have had their tonsils and/or adenoids removed, new research has found. [More]
AHS provides updated assessment of treatments for acute migraine

AHS provides updated assessment of treatments for acute migraine

The January issue of the American Headache Society journal Headache provides an updated assessment of the best treatments to use when a migraine attack occurs. The assessment will form the basis of new AHS treatment guidelines. [More]
Improving headache treatment could reduce health care spending, new study suggests

Improving headache treatment could reduce health care spending, new study suggests

Each year more than 12 million Americans visit their doctors complaining of headaches, which result in lost productivity and costs of upward of $31 billion annually. A new study by researchers from Beth Israel Deaconess Medical Center suggests some of that cost could be offset by physicians ordering fewer tests and an increased focus on counseling about lifestyle changes. [More]
Infectious disease specialist underscores the importance of flu vaccines

Infectious disease specialist underscores the importance of flu vaccines

Flu season is in full swing, but it's not too late to get a flu vaccine. In fact, it's never been easier and more convenient. [More]
Three IU researchers receive $2.1 million to develop computational biology models of liver toxicity

Three IU researchers receive $2.1 million to develop computational biology models of liver toxicity

Three Indiana University professors have received $2.1 million to develop a computational model of acetaminophen-induced liver failure -- the leading cause of liver failure in the United States -- by using advanced microscopic and computational technologies that allow scientists to see into the liver of a living animal. [More]
New guideline now available to help prevent, treat delirium in older patients

New guideline now available to help prevent, treat delirium in older patients

A new guideline is available to help health care providers prevent and treat one of the most common postoperative complications in older patients, delirium, which is an episode of sudden confusion. [More]
Physical pain and social pain use distinct neural circuits, new study reveals

Physical pain and social pain use distinct neural circuits, new study reveals

Over the last decade, neuroscientists have largely come to believe that physical pain and social pain are processed by the brain in the same way. But a new study led by the University of Colorado shows that the two kinds of pain actually use distinct neural circuits, a finding that could lead to more targeted treatments and a better understanding of how the two kinds of pain interact. [More]
Researchers find frequency, severity of medication errors among young children

Researchers find frequency, severity of medication errors among young children

According to Nationwide Children's Hospital researchers, 63,000 children under the age of six experienced out-of-hospital medication errors annually between 2002 and 2012. One child is affected every eight minutes, usually by a well-meaning parent or caregiver unintentionally committing a medication error. [More]
Preoperative IV ibuprofen improves quality of recovery after laparoscopic cholecystectomy surgery

Preoperative IV ibuprofen improves quality of recovery after laparoscopic cholecystectomy surgery

Cumberland Pharmaceuticals Inc. today announced that preoperative intravenous ibuprofen improved overall quality of recovery in patients undergoing laparoscopic cholecystectomy surgery. These results will be presented at the American Anesthesiology 2014 Annual Meeting in New Orleans, Louisiana. [More]
AAN releases new position statement on opioids for chronic non-cancer pain

AAN releases new position statement on opioids for chronic non-cancer pain

According to a new position statement from the American Academy of Neurology, the risk of death, overdose, addiction or serious side effects with prescription opioids outweigh the benefits in chronic, non-cancer conditions such as headache, fibromyalgia and chronic low back pain. [More]

Teva Canada recalls Biomedic Acetaminophen with Codeine owing to missing child-resistant packaging

Teva Canada Limited, in consultation with Health Canada, is recalling one lot (#669745) of Biomedic Acetaminophen with Codeine (30 caplets with 300 mg acetaminophen and 8 mg codeine) due to missing child-resistant packaging. [More]
AAC issues safety message to consumers about cold and flu medicines

AAC issues safety message to consumers about cold and flu medicines

As the countdown to cold and flu season begins, consumers are getting flu shots and increasing their purchases of cold and flu medicines. The Acetaminophen Awareness Coalition is issuing a safety message to consumers, reminding them to double check their medicine labels to avoid doubling up on medicines with acetaminophen when treating symptoms during the upcoming cold and flu season. [More]
KemPharm to initiate clinical trials in Canada for lead product candidate KP201

KemPharm to initiate clinical trials in Canada for lead product candidate KP201

KemPharm, Inc., a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular entity (NME) prodrugs, announced today that it received a No Objection Letter (NOL) from Health Canada to begin clinical trials in Canada for its lead product candidate KP201 (benzhydrocodone hydrochloride and acetaminophen) [More]
Liver injury caused by herbals and dietary supplements increases 20% in U.S. study group

Liver injury caused by herbals and dietary supplements increases 20% in U.S. study group

New research shows that liver injury caused by herbals and dietary supplements increased from 7% to 20% in a U.S. study group over a ten-year period. [More]
Review of clinical trials based on administering antidepressants for chronic postsurgical pain

Review of clinical trials based on administering antidepressants for chronic postsurgical pain

After a systematic review of clinical trials based on administering antidepressants for acute and chronic postsurgical pain, researchers have concluded that more trials are needed to determine whether these drugs should be prescribed for postsurgical pain on a regular basis. [More]
Paracetamol safety and osteoarthritis: an interview with Professor David Hunter, University of Sydney

Paracetamol safety and osteoarthritis: an interview with Professor David Hunter, University of Sydney

Firstly, paracetamol has been the first-line recommended treatment for osteoarthritis pain for very many years and, secondly, it is readily available over the counter and can be bought in relatively large quantities. [More]
Mitek Sports Medicine expands early intervention options for sports medicine physicians and patients

Mitek Sports Medicine expands early intervention options for sports medicine physicians and patients

Mitek Sports Medicine, a leader in orthopaedics sports medicine and a part of the DePuy Synthes Companies of Johnson & Johnson, announced the launch of MONOVISC High Molecular Weight Hyaluronan, a single-injection treatment for knee pain related to osteoarthritis and the PEAK Platelet Rich Plasma (PRP) System, a new device that produces high quality PRP in only 2.5 minutes. [More]
Pain control in osteoarthritis patients: an interview with Dr. Clarence Young, Chief Medical Officer and John Vavricka, President and CEO, Iroko Pharmaceuticals

Pain control in osteoarthritis patients: an interview with Dr. Clarence Young, Chief Medical Officer and John Vavricka, President and CEO, Iroko Pharmaceuticals

Osteoarthritis (OA) is one of the most common causes of disability, and inadequate pain control can lead to joint stiffness that may impair mobility for patients. [More]

Wake Forest Baptist Physician offers tips to prevent bites and rashes in summer

When summer rolls around, nothing beats soaking up the rays, hiking in a forest or playing Frisbee with the family … until a mosquito, bee or poisonous plant ruins the fun. [More]